Patents Assigned to Venturis Therapeutics, Inc.
  • Patent number: 10966610
    Abstract: Devices, methods, systems and procedures for localized, targeted treatment of angiogenic-based therapy in at least one region of interest in one or more layers of cardiac tissue. Various methods can include diagnosing a patient with ischemic heart disease or “at-risk” of manifesting ischemic heart disease, placing the patient into a specific angiogenic-based treatment therapy group, collecting image data, confirming image data and other diagnostic test results, developing a preoperative plan to target region of interest, inserting the catheter into a heart chamber, monitoring the distal end of the catheter tip within the heart on a visual display, contacting at least one layer of cardiac tissue, creating one or more channels in the heart tissue and/or administering the angiogenic-based therapy.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: April 6, 2021
    Assignees: Venturis Therapeutics, Inc.
    Inventors: Vance Gardner, Kenneth Thomas, John Jacobs, Thomas Stegmann, Mickael Flaa, Laurence R. Meyerson